Prof. Elihu (Eli) H. Estey, MD, a pioneering AML researcher, physician and scholar collapsed and died unexpectedly on Oct. 8 at his home in Seattle. He was 75.
Our good friend and colleague Ed Gehan passed away on Sept. 28 at the age of 92. Ed and his contributions to cancer research and to cancer patients are legend.
David Morse Livingston, a Dana-Farber Cancer Institute scientist who made key discoveries and forged novel collaborations that opened new paths in cancer science, died suddenly Oct. 17. Livingston was 80.
Joseph R. Bertino, a physician who made fundamental discoveries in cancer biology, defined curative cancer treatment regimens, trained generations of influential cancer researchers, ran productive laboratories, and served as the inaugural director of Yale Cancer Center, died on Oct. 10. He was 91.
My dear friend and mentor, Joseph R. Bertino, MD, died Sunday, Oct. 10, 2021, in New Brunswick, NJ, after an extended illness.
Thomas A. Waldmann, chief emeritus of the NCI Lymphoid Malignancies Branch and NIH Distinguished Investigator, died Sept. 25. He was 91.
Martin “Mac” Cheever, a Fred Hutchinson Cancer Research Center physician-scientist who was a pioneer in the development of immunotherapies, died on Sept. 23 from complications following heart surgery. He was 77. Friends and colleagues note Cheever’s calm demeanor, generosity and wit. As an oncologist, he was respected for his work as one of the first […]
Franco Muggia, a drug developer and former director of NYU Langone’s Perlmutter Cancer Center, died unexpectedly on Sept. 8.
John F. Potter, founder of the Georgetown Lombardi Comprehensive Cancer Center, died June 28, at MedStar Georgetown University Hospital, the site of his greatest professional triumphs. He was 95.
José Baselga, an expert in the development of molecular targeted agents and an executive at AstraZeneca, died of Creutzfeldt-Jakob, an extremely rare, rapidly progressing, degenerative brain disorder.
